Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study to evaluate the effects of two doses of nalbuphine HCl ER
tablets on the change from baseline in the worst itch Numerical Rating Scale (NRS) in
hemodialysis patients with moderate to severe uremic pruritus and to evaluate the safety and
tolerability in the study population.